Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them.
Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. The company is focused on developing innovative drugs for diseases with a genetic basis and is leading the field in bringing the promise of RNAi to address diseases outside of the liver.
Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them.
Arrowhead Pharmaceuticals